Stocks Overview

LAST PRICE
27.7700
TODAY'S CHANGE (%)
Trending Down-0.7800 (-2.7320%)

Bid / Lots
26.5000/ 1
Ask / Lots
28.7200/ 1
Open / Previous Close
27.9000 / 28.5500
Day Range
Low 27.7500
High 28.1100
52 Week Range
Low 26.3200
High 42.7200
Volume
291,606
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 28.55
Time	Volume	GMAB
09:32 ET	7147	27.835
09:34 ET	420	27.82
09:36 ET	4310	27.815
09:38 ET	200	27.82
09:39 ET	3129	27.77
09:41 ET	300	27.775
09:43 ET	293	27.79
09:45 ET	200	27.81
09:48 ET	600	27.82
09:50 ET	1487	27.81
09:52 ET	400	27.825
09:54 ET	200	27.78
09:56 ET	280	27.75
09:57 ET	1100	27.78
09:59 ET	1458	27.79
10:01 ET	1300	27.835
10:03 ET	500	27.85
10:06 ET	679	27.8599
10:08 ET	1379	27.85
10:10 ET	3019	27.84
10:12 ET	300	27.83
10:14 ET	200	27.86
10:15 ET	900	27.89
10:17 ET	700	27.91
10:19 ET	3122	27.96
10:21 ET	2900	27.905
10:24 ET	671	28
10:26 ET	1845	27.97
10:28 ET	400	27.98
10:30 ET	1801	27.98
10:32 ET	200	27.9923
10:33 ET	1950	27.98
10:37 ET	571	28.02
10:39 ET	200	28.04
10:42 ET	500	28.055
10:44 ET	6866	28.06
10:46 ET	900	28.06
10:48 ET	1209	28.05
10:50 ET	100	28.055
10:51 ET	1038	28.09
10:53 ET	250	28.11
10:55 ET	713	28.08
10:57 ET	300	28.045
11:00 ET	1823	28.02
11:02 ET	100	28.02
11:06 ET	2892	27.9907
11:08 ET	800	27.98
11:09 ET	400	27.995
11:11 ET	100	28
11:15 ET	501	28.015
11:18 ET	405	28.01
11:20 ET	301	28.01
11:22 ET	200	28.01
11:24 ET	541	28.03
11:29 ET	410	28.03
11:31 ET	888	28.04
11:33 ET	100	28.04
11:38 ET	300	28.03
11:40 ET	200	28.04
11:42 ET	100	28.025
11:44 ET	200	28.015
11:45 ET	450	27.98
11:47 ET	930	27.97
11:49 ET	557	27.9673
11:51 ET	1634	27.97
11:54 ET	500	27.975
11:56 ET	2755	27.98
11:58 ET	2216	28.02
12:00 ET	2298	28
12:02 ET	200	27.99
12:03 ET	700	27.995
12:05 ET	1072	28
12:07 ET	435	28
12:12 ET	658	28.03
12:14 ET	600	28.01
12:18 ET	400	28
12:20 ET	580	28
12:21 ET	100	27.99
12:23 ET	1050	27.99
12:25 ET	1550	27.97
12:27 ET	1809	27.94
12:32 ET	100	27.96
12:34 ET	1552	27.95
12:36 ET	354	27.96
12:38 ET	1320	27.93
12:43 ET	785	27.905
12:45 ET	400	27.92
12:48 ET	100	27.9
12:50 ET	100	27.9
12:52 ET	300	27.9
12:54 ET	808	27.91
12:56 ET	1073	27.905
12:57 ET	100	27.91
12:59 ET	200	27.925
01:06 ET	820	27.9
01:08 ET	320	27.905
01:10 ET	330	27.9
01:12 ET	600	27.91
01:14 ET	474	27.91
01:19 ET	1400	27.915
01:21 ET	1008	27.926
01:24 ET	1943	27.945
01:26 ET	890	27.95
01:30 ET	1160	27.91
01:32 ET	200	27.91
01:33 ET	521	27.91
01:35 ET	300	27.92
01:37 ET	245	27.91
01:39 ET	100	27.93
01:42 ET	725	27.88
01:46 ET	100	27.88
01:48 ET	2049	27.89
01:50 ET	220	27.89
01:51 ET	900	27.88
01:53 ET	1900	27.86
01:55 ET	108	27.8777
01:57 ET	260	27.87
02:00 ET	510	27.89
02:02 ET	2053	27.86
02:04 ET	602	27.8467
02:06 ET	2845	27.855
02:09 ET	600	27.84
02:13 ET	2850	27.87
02:15 ET	818	27.86
02:20 ET	778	27.86
02:22 ET	1400	27.88
02:24 ET	300	27.89
02:26 ET	700	27.88
02:27 ET	309	27.8928
02:29 ET	228	27.89
02:31 ET	700	27.87
02:33 ET	100	27.85
02:36 ET	700	27.85
02:38 ET	400	27.85
02:40 ET	700	27.86
02:42 ET	433	27.86
02:45 ET	1095	27.865
02:47 ET	481	27.86
02:49 ET	185	27.8671
02:51 ET	399	27.855
02:54 ET	750	27.86
02:56 ET	1313	27.88
02:58 ET	1100	27.85
03:00 ET	100	27.85
03:02 ET	888	27.85
03:03 ET	400	27.85
03:05 ET	400	27.85
03:07 ET	1000	27.86
03:09 ET	100	27.86
03:12 ET	2063	27.86
03:14 ET	674	27.85
03:16 ET	600	27.85
03:20 ET	574	27.85
03:23 ET	1906	27.8595
03:25 ET	1368	27.83
03:27 ET	1301	27.845
03:30 ET	1200	27.85
03:32 ET	1850	27.84
03:34 ET	331	27.8528
03:36 ET	3165	27.84
03:38 ET	100	27.84
03:39 ET	2526	27.83
03:41 ET	1600	27.84
03:43 ET	3950	27.82
03:45 ET	900	27.83
03:48 ET	1938	27.82
03:50 ET	600	27.81
03:52 ET	7182	27.795
03:54 ET	300	27.795
03:56 ET	8467	27.79
03:57 ET	6308	27.795
03:59 ET	38903	27.77

Data delayed at least 15 minutes.

Jun 7, 2024
- DJ Genmab A/S Stock Falls Friday, Underperforms Market, from 12:01PM ET on Friday Jun 07, 2024 by Dow Jones
  12:01PM ET on Friday Jun 07, 2024 by Dow Jones
Jun 4, 2024
- DJ Genmab Is Maintained at Buy by Truist Securities, from 9:04AM ET on Tuesday Jun 04, 2024 by Dow Jones
  9:04AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
- DJ Genmab A/S Stock Rises Monday, Outperforms Market, from 12:01PM ET on Monday Jun 03, 2024 by Dow Jones
  12:01PM ET on Monday Jun 03, 2024 by Dow Jones
- Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), from 9:00AM ET on Monday Jun 03, 2024 by Dow Jones
  9:00AM ET on Monday Jun 03, 2024 by Dow Jones
- DJ Genmab Price Target Maintained With a $50.00/Share by HC Wainwright & Co., from 6:44AM ET on Monday Jun 03, 2024 by Dow Jones
  6:44AM ET on Monday Jun 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesGMAB Genmab A/S	18.7B	23.0x	+22.71%
United StatesDNLI Denali Therapeutics Inc	2.9B	-21.5x	---
United StatesFOLD Amicus Therapeutics Inc	3.0B	-20.4x	---
United StatesTWST Twist Bioscience Corp	2.7B	-15.1x	---
United StatesMOR MorphoSys AG	2.8B	-5.3x	---
United StatesGLPG Galapagos NV	1.8B	52.8x	---
As of 2024-06-09

Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Contact Information

Headquarters: Carl Jacobsens Vej 30KOEBENHAVN V, Denmark 2500
Phone: ---
Fax: ---

Executives

Independent Chairman of the Board: Deirdre Connelly
President, Chief Executive Officer: Jan Van De Winkel
Independent Deputy Chairman of the Board: Pernille Erenbjerg
Chief Financial Officer, Executive Vice President: Anthony Pagano
Chief Operating Officer, Executive Vice President: Anthony Mancini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$18.7B
Revenue (TTM)	$2.6B
Shares Outstanding	661.3M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.99
EPS	$1.21
Book Value	$7.05
P/E Ratio	23.0x
Price/Sales (TTM)	7.2
Price/Cash Flow (TTM)	---
Operating Margin	32.00%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Genmab A/S
NASDAQ:GMABUnited States

Search Criteria

Charts

Recent News

Jun 7, 2024

DJ Genmab A/S Stock Falls Friday, Underperforms Market, from 12:01PM ET on Friday Jun 07, 2024 by Dow Jones

Jun 4, 2024

DJ Genmab Is Maintained at Buy by Truist Securities, from 9:04AM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 3, 2024

DJ Genmab A/S Stock Rises Monday, Outperforms Market, from 12:01PM ET on Monday Jun 03, 2024 by Dow Jones

Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), from 9:00AM ET on Monday Jun 03, 2024 by Dow Jones

DJ Genmab Price Target Maintained With a $50.00/Share by HC Wainwright & Co., from 6:44AM ET on Monday Jun 03, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar